"He was one of the most prolific investigators in the area of postoperative pain management. His fraud sets back our knowledge in the field tremendously.” Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia.
"The study started out with 20 subjects…For about a week there were 14 subjects. Then they started dropping…Now, we’re down to 7."
The majority of persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of committing suicide.
Pfizer’s smoking cessation drug, Chantix (varenicline), may be the most dangerous drug ever to carry the government seal of approval–it poses a danger, not just to those who ingest the drug, but to people in the community in which they live.
The FDA announced that the postmarketing trial of Avandia, known as TIDE, has been placed on "partial clinical hold." No new patients may be enrolled in the trial.
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1]
"any slipshod work involving volunteers in clinical trials sends a shudder through the field," said Dr. Gary Small, a professor of psychiatry and biobehavioral sciences at UCLA
“There could be a patient safety issue, for one, and there could be a scientific validity issue. If you’re exposing people to radiation and getting garbage data, then that becomes an ethical problem.”
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"
Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
The dust-up involving Dr. Charles Nemeroff and Dr. Thomas Insell, director of NIMH shines a light on NIH leaders whose failure to enforce federal disclosure requirements is brushed off with excuses so untenable they have the ring of theater of the absurd.
"Dr. Nemeroff has become the poster child for what’s wrong with academic medicine in our country." Dr. Thomas Insell, Director of the NIMH, quietly helped him get a prized position at the University of Miami.
